113 related articles for article (PubMed ID: 28984683)
1. Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells.
Fang CY; Chen JS; Chang SK; Shen CH
Anticancer Drugs; 2018 Jan; 29(1):29-39. PubMed ID: 28984683
[TBL] [Abstract][Full Text] [Related]
2. Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.
Lee YR; Wu WC; Ji WT; Chen JY; Cheng YP; Chiang MK; Chen HR
J Biomed Sci; 2012 Jan; 19(1):9. PubMed ID: 22283874
[TBL] [Abstract][Full Text] [Related]
3. Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.
Park YL; Ha SY; Park SY; Choi JH; Jung MW; Myung DS; Kim HS; Joo YE
Int J Oncol; 2019 May; 54(5):1875-1883. PubMed ID: 30864676
[TBL] [Abstract][Full Text] [Related]
4. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.
Carlos JAEG; Lima K; Coelho-Silva JL; de Melo Alves-Paiva R; Moreno NC; Vicari HP; de Souza Santos FP; Hamerschlak N; Costa-Lotufo LV; Traina F; Machado-Neto JA
Cell Oncol (Dordr); 2020 Dec; 43(6):1191-1201. PubMed ID: 32857324
[TBL] [Abstract][Full Text] [Related]
5. Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.
Lu YC; Lee YR; Liao JD; Lin CY; Chen YY; Chen PT; Tseng YS
PLoS One; 2016; 11(7):e0158587. PubMed ID: 27385117
[TBL] [Abstract][Full Text] [Related]
6. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.
D'Alise AM; Amabile G; Iovino M; Di Giorgio FP; Bartiromo M; Sessa F; Villa F; Musacchio A; Cortese R
Mol Cancer Ther; 2008 May; 7(5):1140-9. PubMed ID: 18483302
[TBL] [Abstract][Full Text] [Related]
7. Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells.
Kuo CH; Lu YC; Tseng YS; Shi CS; Chen SH; Chen PT; Wu FL; Chang YP; Lee YR
Breast Cancer; 2014 May; 21(3):358-69. PubMed ID: 22926505
[TBL] [Abstract][Full Text] [Related]
8. Preferential killing of p53-deficient cancer cells by reversine.
Jemaà M; Galluzzi L; Kepp O; Boilève A; Lissa D; Senovilla L; Harper F; Pierron G; Berardinelli F; Antoccia A; Castedo M; Vitale I; Kroemer G
Cell Cycle; 2012 Jun; 11(11):2149-58. PubMed ID: 22592527
[TBL] [Abstract][Full Text] [Related]
9. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux.
Li JR; Cheng CL; Yang CR; Ou YC; Wu MJ; Ko JL
Toxicol Lett; 2013 Jul; 220(3):267-76. PubMed ID: 23651616
[TBL] [Abstract][Full Text] [Related]
10. Autophagy induction of reversine on human follicular thyroid cancer cells.
Lu CH; Liu YW; Hua SC; Yu HI; Chang YP; Lee YR
Biomed Pharmacother; 2012 Dec; 66(8):642-7. PubMed ID: 23089471
[TBL] [Abstract][Full Text] [Related]
11. Autophagy inhibition by reversine and its suppressive effects on human hepatocellular carcinoma cells.
Zhu L; Wu Q; Quan B; Yang J; Yang J; Hou W; Cheng L
Biochem Biophys Res Commun; 2020 Jul; 528(1):105-111. PubMed ID: 32456791
[TBL] [Abstract][Full Text] [Related]
12. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
13. G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.
Li F; Zeng J; Gao Y; Guan Z; Ma Z; Shi Q; Du C; Jia J; Xu S; Wang X; Chang L; He D; Guo P
PLoS One; 2015; 10(9):e0138390. PubMed ID: 26397365
[TBL] [Abstract][Full Text] [Related]
14. Effect of reversine on cell cycle, apoptosis, and activation of hepatic stellate cells.
Huang Y; Huang D; Weng J; Zhang S; Zhang Q; Mai Z; Gu W
Mol Cell Biochem; 2016 Dec; 423(1-2):9-20. PubMed ID: 27734224
[TBL] [Abstract][Full Text] [Related]
15. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
16. A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
Wang L; Šuštić T; Leite de Oliveira R; Lieftink C; Halonen P; van de Ven M; Beijersbergen RL; van den Heuvel MM; Bernards R; van der Heijden MS
Eur Urol; 2017 Jun; 71(6):858-862. PubMed ID: 28108151
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase.
Hiruma Y; Koch A; Dharadhar S; Joosten RP; Perrakis A
Proteins; 2016 Dec; 84(12):1761-1766. PubMed ID: 27699881
[TBL] [Abstract][Full Text] [Related]
18. The synthetic purine reversine selectively induces cell death of cancer cells.
Piccoli M; Palazzolo G; Conforti E; Lamorte G; Papini N; Creo P; Fania C; Scaringi R; Bergante S; Tringali C; Roncoroni L; Mazzoleni S; Doneda L; Galli R; Venerando B; Tettamanti G; Gelfi C; Anastasia L
J Cell Biochem; 2012 Oct; 113(10):3207-17. PubMed ID: 22615034
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent.
Ojha R; Singh SK; Bhattacharyya S; Dhanda RS; Rakha A; Mandal AK; Jha V
J Urol; 2014 Jun; 191(6):1889-98. PubMed ID: 24440234
[TBL] [Abstract][Full Text] [Related]
20. Reversine triggers mitotic catastrophe and apoptosis in K562 cells.
Rodrigues Alves AP; Machado-Neto JA; Scheucher PS; Paiva HH; Simões BP; Rego EM; Traina F
Leuk Res; 2016 Sep; 48():26-31. PubMed ID: 27447890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]